Pricing Log in Create free account

Immuneering Corporation (IMRX) vs Lexeo Therapeutics, Inc. (LXEO)

Immuneering Corporation and Lexeo Therapeutics, Inc. are both Biotechnology companies. Immuneering Corporation and Lexeo Therapeutics, Inc. are of similar size ($238.3M and $237.2M). Across the 10 metrics below, Immuneering Corporation leads on 7 and Lexeo Therapeutics, Inc. on 3.

Valuation

Metric IMRX LXEO Biotechnology median
P/E n/m n/m 10.60
P/S 751.21 n/m 9.40
P/B 1.41 1.05 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 292.52 n/m 9.02
Earnings yield (28.10%) (39.79%) (32.88%)
Free cash flow yield (25.95%) (35.85%) (23.13%)

Profitability

Metric IMRX LXEO Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.53%) (46.76%) (51.96%)
Return on assets (31.40%) (40.50%) (46.06%)
Return on invested capital (198.38%) (253.48%) 0.00%

Growth

Metric IMRX LXEO Biotechnology median
Revenue growth (TTM) (84.76%) — 6.76%
EPS growth (last fiscal year) 37.75% 39.81% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRX LXEO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.97 13.89 4.97
Net debt to EBITDA 2.94 1.67 1.01

Dividend

Metric IMRX LXEO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMRX LXEO Biotechnology median
Market cap 238.33m 237.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack